Original Research
Published on 05 Feb 2025
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 375 views